Table 3.
Pathological characteristics and long-term outcomes
| Quality of mesorectal excision, n (%) | |
| Complete | 115 (94.3) |
| Near complete | 5 (4.1) |
| Incomplete | 2 (1.6) |
| CRM negative, n (%) | 119 (97.5) |
| Distal margin negative, n (%) | 122 (100) |
| TMN stage, n (%) | |
| 0 | 18 (14.8) |
| I | 36 (29.5) |
| IIa | 31 (25.4) |
| IIb | 4 (3.3) |
| IIIa | 12 (9.8) |
| IIIb | 12 (9.8) |
| IIIc | 9 (7.4) |
| T stage | |
| Tis | 10 (8.2) |
| T0 | 9 (7.4) |
| T1 | 28 (23) |
| T2 | 29 (23.7) |
| T3 | 36 (29.5) |
| T4 | 10 (8.2) |
| N stage | |
| N0 | 89 (72.9) |
| N1 | 28 (23) |
| N2 | 5 (4.1) |
| Tumor dimension (cm), mean (± SD) | 2.6 (± 1.6) |
| Lymph nodes harvested, mean (± SD) | 11 (± 5.3) |
| Follow-up, months mean (± SD) | 32 (± 22.5) |
| Adjuvant treatment, n (%) | 52 (42.6) |
| Recurrence, n (%) | 7 (5.8) |
| Local | 2 |
| Locale + distant | 1 |
| Distant | 4 |
| Mortality at follow up, n (%) | 5 (4.1) |